First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof ...

Last week, U.S. consumer groups and labour unions petitioned the U.S. Federal Trade Commission to block Novo Holdings, the ...

Moving ahead, Rob Rowe, Regional Research Director and Head of Global Strategy at a large US bank is ‘ tactically bullish ’ on the back of continuing tech recovery and the markets “pricing in a soft ...

Alzheimer’s causes a gradual decline in memory, thinking, behaviour, and social skills, and it is the most common cause of ...

As more Big Pharma companies have launched direct-to-consumer telehealth platforms, lawmakers have raised concerns they might ...

On July 1, IUPUI was split into Indiana University Indianapolis and Purdue University in Indianapolis. Purdue’s Indianapolis ...

The FDA recalled delayed-release capsules of duloxetine because they contain nitrosamines, which are everywhere but can be ...

A new Alzheimer’s treatment from US firm Eli Lilly was approved for use this week by the UK drug regulator MHRA, although disappointingly for its maker, the drug won’t be available on the NHS as it ...

This week, Roche joined Eli Lilly in coming out against a deal that would add significant new manufacturing capacity to Novo ...

Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Novartis (NVS) and Eli Lilly (LLY). But which of these two stocks is more attractive to value ...

In our latest round-up, we look at Amazon being set to launch ‘Low-Cost Store’, Arm cancelling an IP licence with Qualcomm, ...

Key drugs from Johnson & Johnson and Eli Lilly stand to bolster their respective cases in competitive dermatology markets ...